Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

US Patent 11497762 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associat2020
Combination for use in treating diseases or conditions associated with melanoma,2019
MiRNA for treating head and neck cancer2019
MiRNA for treating diseases and conditions associated with neo-angiogenesis2018
MiRNA molecule defined by its source and its diagnostic and therapeutic uses in 2018
MiRNA and its diagnostic and therapeutic uses in diseases or conditions associat2017
MiRNA for treating diseases and conditions associated with neo-angiogenesis2016
MiRNA molecule defined by its source and its diagnostic and therapeutic uses in 2015